Researchers have found that nanotechnology can increase chemotherapy's effectiveness. The new research could be good news for people who develop peritoneal cancer in the future. "This patient group ...
Safety of preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma: An interim safety ...
PPC is a type of cancer that starts in the peritoneal cavity in the abdomen, rather than cancer that has developed elsewhere in the body and spread to the peritoneum. Cancer that has started elsewhere ...
Two randomized controlled trials, one comparative study, one multi-institutional registry study, and 10 most recent case-series studies were evaluated. The level of evidence was low in 13 of the 14 ...
This procedure can only be done as part of a research study. This is because there is not enough evidence to be sure how well it works. Peritoneal carcinomatosis is cancer that has spread inside the ...
FDA approved a PD-L1 companion test to identify patients with ovarian, fallopian tube or primary peritoneal cancer who may receive Keytruda. The U.S. Food and Drug Administration (FDA) has approved PD ...
The overall decline was mainly driven by decreased incidences of epithelial cancers in the ovaries, fallopian tubes, or peritoneum, as well as a decrease in the number of patients diagnosed with ...
Evidence-based recommendations on pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis in adults. This involves spraying the inside of the peritoneal cavity with chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results